Position in LLY
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$18,240,932
+$4,253,070 QoQ
Shares Held
15,208
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.51%
of 13F equity value
Holder Rank
#932
of 4,621 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Kintegral Advisory, LLC holds $82,893,440 across 8 Drug Manufacturers - General names. LLY ranks #1 (22.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
15,208 | $18,240,932 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
115,097 | $14,541,354 | |
| 3 | ABBV |
AbbVie Inc.
|
52,394 | $13,184,426 | |
| 4 | MRK |
Merck & Co., Inc.
|
91,933 | $11,813,390 | |
| 5 | AMGN |
Amgen Inc
|
29,489 | $10,678,556 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
116,111 | $6,690,315 | |
| 7 | BIIB |
Biogen Inc.
|
17,946 | $3,877,412 | |
| 8 | PFE |
Pfizer Inc
|
160,592 | $3,867,055 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,240,932 | 15,208 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $13,987,862 | 15,208 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $17,068,069 | 15,882 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $12,449,871 | 16,317 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $12,776,496 | 16,390 | Shares | Defined | 2025-07-25 | |
| 2025-03-31 | $13,557,312 | 16,415 | Shares | Defined | 2025-07-21 | |
| 2024-12-31 | $12,715,612 | 16,471 | Shares | Defined | 2025-02-03 | |
| 2024-09-30 | $15,272,719 | 17,239 | Shares | Defined | 2024-11-04 | |
| 2024-06-30 | $15,812,461 | 17,465 | Shares | Defined | 2024-07-26 | |
| 2024-03-31 | $12,365,674 | 15,895 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $9,294,659 | 15,945 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $8,619,325 | 16,047 | Shares | Defined | 2023-10-12 | |
| 2023-06-30 | $7,530,411 | 16,057 | Shares | Defined | 2023-08-02 | |
| 2023-03-31 | $5,514,294 | 16,057 | Shares | Defined | 2023-04-27 | |
| 2022-12-31 | $6,190,012 | 16,920 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,563,317 | 11,020 | Shares | Defined | 2022-11-02 | |
| 2022-06-30 | $3,573,014 | 11,020 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $3,089,073 | 10,787 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,913,016 | 10,546 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $2,436,653 | 10,546 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $2,420,517 | 10,546 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,970,203 | 10,546 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $1,780,586 | 10,546 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $1,561,018 | 10,546 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,787,099 | 10,885 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $1,509,967 | 10,885 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||